ARRY-334543
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARRY-334543, covering 2012-10-04 to 2012-10-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer [Phase 1, Phase 2]